首页 > 最新文献

Infection and Drug Resistance最新文献

英文 中文
Retrospective Analysis of the Efficacy and Safety of Endoscopic Spinal Tuberculosis and Brucellosis Lesion Removal and Posterior Pedicle Lesion Removal, Bone Grafting, Internal Fixation and Surgery Combined with Medical Chemotherapy in the Treatment of Spinal Tuberculosis and Brucellosis. 回顾性分析内窥镜下脊柱结核和布鲁氏菌病病灶清除术和后椎弓根病灶清除术、植骨术、内固定术和手术联合药物化疗治疗脊柱结核和布鲁氏菌病的有效性和安全性。
IF 2.9 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-08-22 eCollection Date: 2024-01-01 DOI: 10.2147/IDR.S472558
Aiben Kayierhan, Abuduwupuer Haibier, Aikebaierjiang Aisaiti, Alimujiang Aximu, Liang Ma, Yuntao Liu, Tuerhongjiang Abudurexiti

Objective: To evaluate the clinical effectiveness of endoscopic removal of spinal infections and posterior pedicle surgery, including bone grafting, fixation, and chemotherapy, and to outline preventive strategies for complications, offering guidance for clinical practice.

Methods: 128 spinal infectious disease patients (2018-2022) were categorized into Group A (endoscopic removal, n=44) and Group B (posterior pedicle removal+bone grafting+fixation, n=84). Pre-surgery, all received quadruple antibiotic therapy. Metrics tracked: operation time, blood loss, drainage, recovery, stay, transfusion, complications, and pre/post-surgery VAS, ODI, ESR, CRP, PCT, D-dimer, NLR, Hb, albumin.

Results: (1) Preoperative data: There were no statistically significant differences in age, gender, body mass index, involved segments, past medical history (cardiovascular and cerebrovascular diseases, respiratory diseases, endocrine system diseases, metabolic diseases and tuberculosis), smoking history, preoperative erythrocyte sedimentation rate, C-reactive protein, procalcitonin, D-dimer, lymphocyte and neutrophil-lymphocyte ratio, hemoglobin, total protein, waist VAS score and waist ODI score (P>0.05). (2) The main postoperative indexes were significantly lower than those of group B at the last follow-up at 3 months and the last follow-up in group A, and the difference was significant (P<0.05), the hemoglobin and total protein in group A were significantly higher than those in group B at the last postoperative follow-up (P<0.05), and the recurrence rate in group B was significantly higher than that in group A, and the difference was significant (P=0.048). (3) Postoperative secondary indicators: the amount of blood transfusion in group A was significantly lower than that in group B, and the difference between the two groups was statistically significant (P<0.05), while the operation time, intraoperative blood loss and postoperative hospital stay in group A were significantly smaller than those in group B, and the difference between the two groups was statistically significant (P<0.05).

Conclusion: Endoscopic lesion removal for spinal infections achieves similar safety to posterior pedicle surgery, with shorter operation time, less blood loss, lower recurrence, and reduced drainage. It enhances ESR, spine function, and pain relief, meriting promotion.

目的评估脊柱感染内镜下切除和后椎弓根手术(包括植骨、固定和化疗)的临床效果,并概述并发症的预防策略,为临床实践提供指导。方法:将128例脊柱感染性疾病患者(2018-2022年)分为A组(内镜下切除,n=44)和B组(后椎弓根切除+植骨+固定,n=84)。手术前,所有患者均接受四重抗生素治疗。跟踪指标:手术时间、失血量、引流量、恢复情况、住院时间、输血量、并发症以及手术前后的 VAS、ODI、ESR、CRP、PCT、D-二聚体、NLR、Hb、白蛋白:年龄、性别、体重指数、受累节段、既往病史(心脑血管疾病、呼吸系统疾病、内分泌系统疾病、代谢性疾病和结核病)、吸烟史、术前红细胞沉降率、C 反应蛋白、降钙素原、D-二聚体、淋巴细胞和中性粒细胞-淋巴细胞比值、血红蛋白、总蛋白、腰部 VAS 评分和腰部 ODI 评分差异无统计学意义(P>0.05)。(2)术后3个月最后一次随访和A组最后一次随访的主要指标均明显低于B组,差异有学意义(PConclusion:内镜下病灶清除术治疗脊柱感染的安全性与后路椎弓根手术相似,具有手术时间短、失血少、复发率低、引流减少等优点。它能提高 ESR,改善脊柱功能,缓解疼痛,值得推广。
{"title":"Retrospective Analysis of the Efficacy and Safety of Endoscopic Spinal Tuberculosis and Brucellosis Lesion Removal and Posterior Pedicle Lesion Removal, Bone Grafting, Internal Fixation and Surgery Combined with Medical Chemotherapy in the Treatment of Spinal Tuberculosis and Brucellosis.","authors":"Aiben Kayierhan, Abuduwupuer Haibier, Aikebaierjiang Aisaiti, Alimujiang Aximu, Liang Ma, Yuntao Liu, Tuerhongjiang Abudurexiti","doi":"10.2147/IDR.S472558","DOIUrl":"10.2147/IDR.S472558","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the clinical effectiveness of endoscopic removal of spinal infections and posterior pedicle surgery, including bone grafting, fixation, and chemotherapy, and to outline preventive strategies for complications, offering guidance for clinical practice.</p><p><strong>Methods: </strong>128 spinal infectious disease patients (2018-2022) were categorized into Group A (endoscopic removal, n=44) and Group B (posterior pedicle removal+bone grafting+fixation, n=84). Pre-surgery, all received quadruple antibiotic therapy. Metrics tracked: operation time, blood loss, drainage, recovery, stay, transfusion, complications, and pre/post-surgery VAS, ODI, ESR, CRP, PCT, D-dimer, NLR, Hb, albumin.</p><p><strong>Results: </strong>(1) Preoperative data: There were no statistically significant differences in age, gender, body mass index, involved segments, past medical history (cardiovascular and cerebrovascular diseases, respiratory diseases, endocrine system diseases, metabolic diseases and tuberculosis), smoking history, preoperative erythrocyte sedimentation rate, C-reactive protein, procalcitonin, D-dimer, lymphocyte and neutrophil-lymphocyte ratio, hemoglobin, total protein, waist VAS score and waist ODI score (P>0.05). (2) The main postoperative indexes were significantly lower than those of group B at the last follow-up at 3 months and the last follow-up in group A, and the difference was significant (P<0.05), the hemoglobin and total protein in group A were significantly higher than those in group B at the last postoperative follow-up (P<0.05), and the recurrence rate in group B was significantly higher than that in group A, and the difference was significant (P=0.048). (3) Postoperative secondary indicators: the amount of blood transfusion in group A was significantly lower than that in group B, and the difference between the two groups was statistically significant (P<0.05), while the operation time, intraoperative blood loss and postoperative hospital stay in group A were significantly smaller than those in group B, and the difference between the two groups was statistically significant (P<0.05).</p><p><strong>Conclusion: </strong>Endoscopic lesion removal for spinal infections achieves similar safety to posterior pedicle surgery, with shorter operation time, less blood loss, lower recurrence, and reduced drainage. It enhances ESR, spine function, and pain relief, meriting promotion.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11346488/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carrimycin in a Patient with Acute Myeloid Leukemia Complicated with Life-Threatening Mixed Perianal Infection: A Case Report and Literature Review. 卡利霉素治疗急性髓性白血病并发危及生命的混合性肛周感染患者:病例报告与文献综述
IF 2.9 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-08-21 eCollection Date: 2024-01-01 DOI: 10.2147/IDR.S475982
Xiawan Yang, Yingying Shen, Tonglin Hu, Hangchao Li, Yun Zhang, Yiping Shen, Dijiong Wu

Background: Perianal infection has a high incidence and mortality rate in patients with acute myeloid leukemia (AML). Sometimes there is a lack of effective anti-infective treatment regimens.

Case presentation: A 58-year-old male diagnosed with AML presented with secondary perianal infection and septic shock upon admission. Although multiple pathogen cultivation and antibiotic sensitivity tests indicated the presence of sensitive strains, the corresponding antibiotics were ineffective. As a last resort, carrimycin was introduced, ultimately controlling the infection and leading to disease remission.

Conclusion: Carrimycin is a complementary treatment option when conventional antibiotic therapy fails. It operates through multiple mechanisms beyond its antibiotic properties and warrants further investigation.

背景:急性髓性白血病(AML)患者肛周感染的发病率和死亡率都很高。有时缺乏有效的抗感染治疗方案:一名 58 岁男性患者被诊断为急性髓性白血病,入院时出现继发性肛周感染和脓毒性休克。虽然多种病原体培养和抗生素敏感试验显示存在敏感菌株,但相应的抗生素均无效。在不得已的情况下,患者使用了卡瑞霉素,最终控制了感染,病情得到缓解:结论:卡瑞霉素是常规抗生素治疗失败后的一种辅助治疗选择。结论:卡瑞霉素是常规抗生素治疗失败后的一种辅助治疗选择,它的作用机制超出了其抗生素特性,值得进一步研究。
{"title":"Carrimycin in a Patient with Acute Myeloid Leukemia Complicated with Life-Threatening Mixed Perianal Infection: A Case Report and Literature Review.","authors":"Xiawan Yang, Yingying Shen, Tonglin Hu, Hangchao Li, Yun Zhang, Yiping Shen, Dijiong Wu","doi":"10.2147/IDR.S475982","DOIUrl":"10.2147/IDR.S475982","url":null,"abstract":"<p><strong>Background: </strong>Perianal infection has a high incidence and mortality rate in patients with acute myeloid leukemia (AML). Sometimes there is a lack of effective anti-infective treatment regimens.</p><p><strong>Case presentation: </strong>A 58-year-old male diagnosed with AML presented with secondary perianal infection and septic shock upon admission. Although multiple pathogen cultivation and antibiotic sensitivity tests indicated the presence of sensitive strains, the corresponding antibiotics were ineffective. As a last resort, carrimycin was introduced, ultimately controlling the infection and leading to disease remission.</p><p><strong>Conclusion: </strong>Carrimycin is a complementary treatment option when conventional antibiotic therapy fails. It operates through multiple mechanisms beyond its antibiotic properties and warrants further investigation.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11345016/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142055443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carrimycin, as One of the Drugs in Combination Therapy, for the Treatment of Carbapenem-Resistant Acinetobacter Baumannii Infection. 卡利霉素作为联合疗法中的一种药物,用于治疗耐碳青霉烯类鲍曼不动杆菌感染。
IF 2.9 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-08-19 eCollection Date: 2024-01-01 DOI: 10.2147/IDR.S468413
Ning Du, Dan You, Dava Tenzing, Dongxiang Qu, Jun Meng, Yihui Wang, Juan He

Purpose: Infection with carbapenem-resistant Acinetobacter baumannii (CRAB) is a tough nut to crack. Carrimycin is a novel recombinant macrolide antibiotic, and has good anti-infection effects in vivo. At present, it is rarely reported for treatment of CRAB infection. We present a case where a patient with COVID-19 complicated by CRAB infection was successfully treated with a combination therapy including carrimycin, offering clinical insights and experience.

Patients and methods: The patient infected with CRAB was cured by carrimycin combined with tigecycline and amikacin ultimately. We analyzed and summarized the therapeutic regimen and disease feature to provide reference for clinical treatment.

Results: The patient was admitted to emergency observation wards with fever and was diagnosed with COVID-19 pneumonia. During the treatment, his condition worsened. He had a fever, cough, and expectoration. After 3 days of empirical treatment with meropenem, tested positive for A. baumannii infection by the next-generation sequencing, and CRAB was detected in blood and sputum culture. Then, he was administered with tigecycline and amikacin immediately for 5 days, however the therapeutic effect was not significant. The patient still remained in a high inflammatory response. Ultimately, the treatment regimen was changed to carrimycin combined with tigecycline and amikacin for 7 days, and then carrimycin combined with tigecycline for 10 days, the patient's clinical condition gradually improved. The patient received carrimycin monotherapy for 7 days, then discharged.

Conclusion: Carrimycin may be a bright alternative for CRAB infection as one of the drugs in combination therapy, especially in a patient with hyperinflammatory response.

目的:耐碳青霉烯类鲍曼不动杆菌(CRAB)感染是一个难以攻克的难题。卡利霉素是一种新型重组大环内酯类抗生素,在体内具有良好的抗感染效果。目前,用于治疗 CRAB 感染的报道很少。我们报告了一例COVID-19并发CRAB感染的患者成功接受包括卡瑞霉素在内的联合治疗的病例,为临床提供启示和经验:患者:感染 CRAB 的患者最终通过卡瑞霉素联合替加环素和阿米卡星治愈。我们对其治疗方案和病情特点进行了分析和总结,为临床治疗提供参考:患者因发热入住急诊观察病房,被诊断为 COVID-19 肺炎。在治疗期间,他的病情恶化。他发烧、咳嗽、咳痰。使用美罗培南经验性治疗 3 天后,经新一代测序检测,鲍曼不动杆菌感染呈阳性,并且在血液和痰培养中检测到 CRAB。随后,他立即接受了替加环素和阿米卡星治疗 5 天,但疗效并不显著。患者仍然处于高度炎症反应中。最终,治疗方案改为卡瑞霉素联合替加环素和阿米卡星治疗 7 天,然后卡瑞霉素联合替加环素治疗 10 天,患者的临床状况逐渐好转。患者接受卡瑞霉素单药治疗 7 天后出院:结论:卡瑞霉素作为联合疗法中的一种药物,可能是治疗 CRAB 感染的一个不错的选择,尤其是对于有高炎症反应的患者。
{"title":"Carrimycin, as One of the Drugs in Combination Therapy, for the Treatment of Carbapenem-Resistant <i>Acinetobacter Baumannii</i> Infection.","authors":"Ning Du, Dan You, Dava Tenzing, Dongxiang Qu, Jun Meng, Yihui Wang, Juan He","doi":"10.2147/IDR.S468413","DOIUrl":"10.2147/IDR.S468413","url":null,"abstract":"<p><strong>Purpose: </strong>Infection with carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) is a tough nut to crack. Carrimycin is a novel recombinant macrolide antibiotic, and has good anti-infection effects in vivo. At present, it is rarely reported for treatment of CRAB infection. We present a case where a patient with COVID-19 complicated by CRAB infection was successfully treated with a combination therapy including carrimycin, offering clinical insights and experience.</p><p><strong>Patients and methods: </strong>The patient infected with CRAB was cured by carrimycin combined with tigecycline and amikacin ultimately. We analyzed and summarized the therapeutic regimen and disease feature to provide reference for clinical treatment.</p><p><strong>Results: </strong>The patient was admitted to emergency observation wards with fever and was diagnosed with COVID-19 pneumonia. During the treatment, his condition worsened. He had a fever, cough, and expectoration. After 3 days of empirical treatment with meropenem, tested positive for <i>A. baumannii</i> infection by the next-generation sequencing, and CRAB was detected in blood and sputum culture. Then, he was administered with tigecycline and amikacin immediately for 5 days, however the therapeutic effect was not significant. The patient still remained in a high inflammatory response. Ultimately, the treatment regimen was changed to carrimycin combined with tigecycline and amikacin for 7 days, and then carrimycin combined with tigecycline for 10 days, the patient's clinical condition gradually improved. The patient received carrimycin monotherapy for 7 days, then discharged.</p><p><strong>Conclusion: </strong>Carrimycin may be a bright alternative for CRAB infection as one of the drugs in combination therapy, especially in a patient with hyperinflammatory response.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11342940/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142055444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genomic Insights into the Pathogenicity and Drug-Resistance of a Bacillus cereus Isolated from Human Teeth. 从人类牙齿中分离出的蜡样芽孢杆菌致病性和耐药性的基因组学启示。
IF 2.9 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-08-19 eCollection Date: 2024-01-01 DOI: 10.2147/IDR.S477637
Yibin Lin, Lehua Liu, Siyang Lu, Linqi Fan, Huaqi Hu, Xuanyin Wang, Jichao Zhu, Xinhua Qiang, Jie He, Hongchang Zhou, Shengwen Shao, Gaoming Zheng

Background: Bacillus cereus is a common bacterium found in the environment. Some strains can cause food poisoning, and very few can cause clinically severe infections, leading to death. Here, we characterized the genome sequence of B. cereus LIN78 isolated from teeth with deep caries and compared it with those of 25 other related species.

Methods: Third-generation sequencing technology, bacteriological analyses, biochemistry, and mass spectrometry were applied to characterize the drug-resistance genes and virulence factors of B. cereus LIN78.

Results: The complete genome sequence of B. cereus Lin78 consists of 5647 genes distributed on a circular chromosome, a 393 kbp plasmid, and 928 pseudogenes (37.4% of whole-genome DNA). The LIN78 genome contains 14 sets of 16s, 23s, and 5s ribosomal RNA operons; 106 tRNA genes, one tmRNA, 12 genomic islands, six prophases, 64 repeats; 37 antibiotic-resistant genes; and 1119 putative virulence genes, including enterotoxins and cytolysins. The B. cereus LIN78 genome carries multiple copies of non-ribosomal polypeptide synthetase (NRPS) and post-translationally modified peptides (RiPPs). Phylogenetic analysis of the 26 B. cereus strains showed that B. cereus LIN78 is evolutionarily closely related to B. thuringiensis ATCC 10792 and B. cereus ATCC 14579.

Conclusion: The newly isolated B. cereus carries many virulence genes, including enterotoxins and hemolysins, similar to B. anthracis, and multiple antibiotic resistance genes. These findings suggest that the strain has a potential risk of causing disease. Our studies are vital for further exploration of the evolution of B. cereus, its pathogenic mechanisms, and the control and treatment of bacterial infections.

背景:蜡样芽孢杆菌是环境中常见的细菌。一些菌株可引起食物中毒,极少数可引起严重的临床感染,导致死亡。在此,我们对从深龋牙中分离出的蜡样芽孢杆菌 LIN78 的基因组序列进行了鉴定,并将其与其他 25 个相关菌种的基因组序列进行了比较:方法:应用第三代测序技术、细菌学分析、生物化学和质谱分析鉴定蜡样芽孢杆菌 LIN78 的耐药基因和毒力因子:结果:蜡样芽孢杆菌 LIN78 的完整基因组序列包括分布在环状染色体上的 5647 个基因、393 kbp 质粒和 928 个假基因(占全基因组 DNA 的 37.4%)。LIN78 基因组包含 14 组 16s、23s 和 5s 核糖体 RNA 操作子;106 个 tRNA 基因、1 个 tmRNA、12 个基因组岛、6 个原体、64 个重复;37 个抗生素耐药基因;以及 1119 个推测毒力基因,包括肠毒素和细胞溶解素。蜡样芽孢杆菌 LIN78 基因组携带多个非核糖体多肽合成酶(NRPS)和翻译后修饰肽(RiPPs)拷贝。对 26 株蜡样芽孢杆菌的系统进化分析表明,蜡样芽孢杆菌 LIN78 在进化上与苏云金芽孢杆菌 ATCC 10792 和蜡样芽孢杆菌 ATCC 14579 关系密切:结论:新分离出的蜡样芽孢杆菌携带许多毒力基因,包括与炭疽杆菌相似的肠毒素和溶血素,以及多种抗生素耐药基因。这些发现表明,该菌株有致病的潜在风险。我们的研究对于进一步探索蜡样芽孢杆菌的进化、致病机制以及细菌感染的控制和治疗至关重要。
{"title":"Genomic Insights into the Pathogenicity and Drug-Resistance of a <i>Bacillus cereus</i> Isolated from Human Teeth.","authors":"Yibin Lin, Lehua Liu, Siyang Lu, Linqi Fan, Huaqi Hu, Xuanyin Wang, Jichao Zhu, Xinhua Qiang, Jie He, Hongchang Zhou, Shengwen Shao, Gaoming Zheng","doi":"10.2147/IDR.S477637","DOIUrl":"10.2147/IDR.S477637","url":null,"abstract":"<p><strong>Background: </strong><i>Bacillus cereus</i> is a common bacterium found in the environment. Some strains can cause food poisoning, and very few can cause clinically severe infections, leading to death. Here, we characterized the genome sequence of <i>B. cereus</i> LIN78 isolated from teeth with deep caries and compared it with those of 25 other related species.</p><p><strong>Methods: </strong>Third-generation sequencing technology, bacteriological analyses, biochemistry, and mass spectrometry were applied to characterize the drug-resistance genes and virulence factors of <i>B. cereus</i> LIN78.</p><p><strong>Results: </strong>The complete genome sequence of <i>B. cereus</i> Lin78 consists of 5647 genes distributed on a circular chromosome, a 393 kbp plasmid, and 928 pseudogenes (37.4% of whole-genome DNA). The LIN78 genome contains 14 sets of 16s, 23s, and 5s ribosomal RNA operons; 106 tRNA genes, one tmRNA, 12 genomic islands, six prophases, 64 repeats; 37 antibiotic-resistant genes; and 1119 putative virulence genes, including enterotoxins and cytolysins. The <i>B. cereus</i> LIN78 genome carries multiple copies of non-ribosomal polypeptide synthetase (NRPS) and post-translationally modified peptides (RiPPs). Phylogenetic analysis of the 26 <i>B. cereus</i> strains showed that <i>B. cereus</i> LIN78 is evolutionarily closely related to <i>B. thuringiensis</i> ATCC 10792 and <i>B. cereus</i> ATCC 14579.</p><p><strong>Conclusion: </strong>The newly isolated <i>B. cereus</i> carries many virulence genes, including enterotoxins and hemolysins, similar to <i>B. anthracis</i>, and multiple antibiotic resistance genes. These findings suggest that the strain has a potential risk of causing disease. Our studies are vital for further exploration of the evolution of <i>B. cereus</i>, its pathogenic mechanisms, and the control and treatment of bacterial infections.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11342944/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142055445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Combined Strategy to Reduce the Pain of Penicillin G Benzathine Injection in Primary Syphilis. 对减轻原发性梅毒患者注射青霉素 G 苯扎西林疼痛的联合策略进行评估
IF 2.9 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-08-17 eCollection Date: 2024-01-01 DOI: 10.2147/IDR.S473416
Yuxia Fang, Yilu Zhao, Lei Qin, Ziyue Song, Ruzhi Zhang

Background: Intramuscular (IM) injection of penicillin G Benzathine (PGB) is widely recognized as the primary treatment for patients at all stages of syphilis. However, the discomfort and induration associated with PGB injections are often a challenge for patients. While lidocaine is already known to reduce injection pain and is standard practice in some countries, the added value of combining lidocaine with the z-track technique has not been thoroughly investigated. This study aims to observe the use of combining lidocaine with the Z-track technique in the treatment of syphilis, and to explore less painful methods of administering IM PGB for the treatment of syphilis in adult patients.

Methods: 32 syphilis patients requiring penicillin treatment were injected with 1.2 million units of penicillin on both sides of the buttocks. The left side was injected using the traditional method with 0.9% saline as the solvent (control Group), while the right side was injected using a "z" injection method with 0.2% lidocaine as the solvent (experimental Group). The success rate of the single injection, the intensity and duration of the post-injection pain and the induration reaction were observed and recorded.

Results: There was no statistically significant difference in single injection success rate and immediate post injection pain score between the two sides (P>0.05). However, the right side had a lower pain score at 30 minutes post injection and fewer induration reactions, showing a statistically significant difference between the two sides (P<0.05). Chi-squared analysis showed that age, gender and BMI had no significant effect on pain scores 30 minutes after injection in either the control or intervention groups. (P>0.05).

Conclusion: The lidocaine + Z-track penicillin method can reduce delayed pain and induration reactions in patients with syphilis, and provides an additional approach to improving patient comfort beyond the standard use of lidocaine alone. This method merits clinical promotion.

背景:青霉素 G-苄青霉素(PGB)的肌肉注射(IM)被广泛认为是梅毒各期患者的主要治疗方法。然而,与 PGB 注射相关的不适感和压痕往往是患者面临的难题。众所周知,利多卡因可减轻注射疼痛,在一些国家已成为标准做法,但将利多卡因与 "Z "形追踪技术相结合的附加值尚未得到深入研究。本研究旨在观察利多卡因与Z-track技术在梅毒治疗中的结合使用情况,并探索在成年患者中使用痛苦较小的IM PGB治疗梅毒的方法。方法:为32名需要青霉素治疗的梅毒患者在臀部两侧注射120万单位青霉素。左侧采用以 0.9% 生理盐水为溶剂的传统注射法(对照组),右侧采用以 0.2% 利多卡因为溶剂的 "z "形注射法(实验组)。观察并记录单次注射的成功率、注射后疼痛的强度和持续时间以及压痕反应:结果:两侧的单次注射成功率和注射后即刻疼痛评分差异无统计学意义(P>0.05)。但右侧在注射后 30 分钟的疼痛评分较低,压痕反应较少,两侧差异有统计学意义(PP>0.05):结论:利多卡因+Z-轨道青霉素法可减少梅毒患者的延迟疼痛和压痕反应,在标准的利多卡因单独使用法之外,为提高患者舒适度提供了另一种方法。这种方法值得临床推广。
{"title":"Evaluation of Combined Strategy to Reduce the Pain of Penicillin G Benzathine Injection in Primary Syphilis.","authors":"Yuxia Fang, Yilu Zhao, Lei Qin, Ziyue Song, Ruzhi Zhang","doi":"10.2147/IDR.S473416","DOIUrl":"10.2147/IDR.S473416","url":null,"abstract":"<p><strong>Background: </strong>Intramuscular (IM) injection of penicillin G Benzathine (PGB) is widely recognized as the primary treatment for patients at all stages of syphilis. However, the discomfort and induration associated with PGB injections are often a challenge for patients. While lidocaine is already known to reduce injection pain and is standard practice in some countries, the added value of combining lidocaine with the z-track technique has not been thoroughly investigated. This study aims to observe the use of combining lidocaine with the Z-track technique in the treatment of syphilis, and to explore less painful methods of administering IM PGB for the treatment of syphilis in adult patients.</p><p><strong>Methods: </strong>32 syphilis patients requiring penicillin treatment were injected with 1.2 million units of penicillin on both sides of the buttocks. The left side was injected using the traditional method with 0.9% saline as the solvent (control Group), while the right side was injected using a \"z\" injection method with 0.2% lidocaine as the solvent (experimental Group). The success rate of the single injection, the intensity and duration of the post-injection pain and the induration reaction were observed and recorded.</p><p><strong>Results: </strong>There was no statistically significant difference in single injection success rate and immediate post injection pain score between the two sides (<i>P</i>>0.05). However, the right side had a lower pain score at 30 minutes post injection and fewer induration reactions, showing a statistically significant difference between the two sides (<i>P</i><0.05). Chi-squared analysis showed that age, gender and BMI had no significant effect on pain scores 30 minutes after injection in either the control or intervention groups. (<i>P>0.05</i>).</p><p><strong>Conclusion: </strong>The lidocaine + Z-track penicillin method can reduce delayed pain and induration reactions in patients with syphilis, and provides an additional approach to improving patient comfort beyond the standard use of lidocaine alone. This method merits clinical promotion.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11338166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142017386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of Metagenomic Next-Generation Sequencing to Identify Pathogens Involved in Central Nervous System Infections. 利用元基因组下一代测序鉴定中枢神经系统感染的病原体。
IF 2.9 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-08-17 eCollection Date: 2024-01-01 DOI: 10.2147/IDR.S474410
Liying Zhan, Zhihua Lv, Yunjing Zhang, Jingdi Chen, Lu Wang, Raojuan Huang, Yaqi Sun, Wei Wu

Purpose: Application of metagenomic next-generation sequencing (mNGS) in identifying nosocomial central nervous system (CNS) infections in critical care units remains understudied.

Methods: We conducted a retrospective analysis of microbiological results through both mNGS and routine examination of cerebrospinal fluid (CSF) samples from patients with nosocomial CNS infections. The aim of this study was to assess the clinical diagnostic effect of nosocomial mNGS in this population.

Results: The study included 26 cases of nosocomial CNS infections in total. A total of 69.2% (18/26) of the samples tested positive for mNGS, which is substantially greater than the 7.7% (2/26; p<0.05) detected through conventional techniques. Administration of antibiotics before culture is most likely the cause of the low CSF culture rate. Twenty-five pathogenic strains that were missed by standard testing. Three pathogens that were consistent with the mNGS results were positive by routine tests. Eight cases were negative by mNGS due to low pathogen CSF titres. Compared to traditional testing, mNGS demonstrated 100% sensitivity and 33.3% specificity in diagnosing CNS infections. The thirty-day mortality rate was 26.9% (7/26).

Conclusion: Routine microbiologic testing frequently falls short of detecting all neuroinvasive pathogens. Our research suggests that mNGS offers an alternative means of detecting nosocomial CNS infections. By applying mNGS to CSF samples from patients with meningitis or encephalitis, we were able to improve the ability to diagnose nosocomial neurologic infections.

目的:元基因组下一代测序(mNGS)在确定重症监护病房的院内中枢神经系统(CNS)感染中的应用仍未得到充分研究:我们通过 mNGS 和常规检查脑脊液 (CSF) 样本,对中枢神经系统感染患者的微生物结果进行了回顾性分析。本研究的目的是评估鼻源性 mNGS 在这一人群中的临床诊断效果:研究共纳入 26 例鼻源性中枢神经系统感染病例。共有 69.2% 的样本(18/26)检测出 mNGS 阳性,远高于 7.7% 的样本(2/26;p):常规微生物检测往往无法检测出所有神经侵入性病原体。我们的研究表明,mNGS 为检测院内中枢神经系统感染提供了另一种方法。通过将 mNGS 应用于脑膜炎或脑炎患者的 CSF 样本,我们能够提高诊断院内神经系统感染的能力。
{"title":"Use of Metagenomic Next-Generation Sequencing to Identify Pathogens Involved in Central Nervous System Infections.","authors":"Liying Zhan, Zhihua Lv, Yunjing Zhang, Jingdi Chen, Lu Wang, Raojuan Huang, Yaqi Sun, Wei Wu","doi":"10.2147/IDR.S474410","DOIUrl":"10.2147/IDR.S474410","url":null,"abstract":"<p><strong>Purpose: </strong>Application of metagenomic next-generation sequencing (mNGS) in identifying nosocomial central nervous system (CNS) infections in critical care units remains understudied.</p><p><strong>Methods: </strong>We conducted a retrospective analysis of microbiological results through both mNGS and routine examination of cerebrospinal fluid (CSF) samples from patients with nosocomial CNS infections. The aim of this study was to assess the clinical diagnostic effect of nosocomial mNGS in this population.</p><p><strong>Results: </strong>The study included 26 cases of nosocomial CNS infections in total. A total of 69.2% (18/26) of the samples tested positive for mNGS, which is substantially greater than the 7.7% (2/26; <i>p</i><0.05) detected through conventional techniques. Administration of antibiotics before culture is most likely the cause of the low CSF culture rate. Twenty-five pathogenic strains that were missed by standard testing. Three pathogens that were consistent with the mNGS results were positive by routine tests. Eight cases were negative by mNGS due to low pathogen CSF titres. Compared to traditional testing, mNGS demonstrated 100% sensitivity and 33.3% specificity in diagnosing CNS infections. The thirty-day mortality rate was 26.9% (7/26).</p><p><strong>Conclusion: </strong>Routine microbiologic testing frequently falls short of detecting all neuroinvasive pathogens. Our research suggests that mNGS offers an alternative means of detecting nosocomial CNS infections. By applying mNGS to CSF samples from patients with meningitis or encephalitis, we were able to improve the ability to diagnose nosocomial neurologic infections.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11339344/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary Tuberculosis Complicated by Thrombotic Thrombocytopenic Purpura: A Case Report and Literature Review. 血栓性血小板减少性紫癜并发肺结核:病例报告和文献综述。
IF 2.9 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-08-17 eCollection Date: 2024-01-01 DOI: 10.2147/IDR.S477180
Jun Zheng, Xiaohong Pan, Yiyun Jiang

Thrombotic thrombocytopenic purpura is a rare but life-threatening emergency. Tuberculosis can have hematologic complications. However, concurrent tuberculosis and thrombotic thrombocytopenic purpura are extremely rare. In this study, we report a 53-year-old man who was initially treated for pulmonary tuberculosis but later developed weakness and an altered mental status. Laboratory tests revealed evidence of thrombocytopenia, acute renal insufficiency, and microangiopathic hemolytic anemia. Brain imaging identified intracranial hemorrhage. Further testing revealed low ADAMTS13 activity (1.8%) and positive anti-ADAMTS13 antibody, confirming the diagnosis of thrombotic thrombocytopenic purpura. The patient had a full recovery after anti-tuberculosis treatment, plasma exchange, and supportive care. We present this rare case and review previous relevant studies to remind clinicians about the potential connections between tuberculosis and thrombotic thrombocytopenic purpura. In patients with signs of severe thrombocytopenia and microangiopathic hemolysis, necessary diagnostic tests should be performed to eliminate the possibility of thrombotic thrombocytopenic purpura occurring concurrently with tuberculosis.

血栓性血小板减少性紫癜是一种罕见但危及生命的急症。肺结核可引起血液系统并发症。然而,结核病和血栓性血小板减少性紫癜并发的情况极为罕见。在本研究中,我们报告了一名 53 岁的男子,他最初因肺结核接受治疗,但后来出现虚弱和精神状态改变。实验室检查显示他患有血小板减少症、急性肾功能不全和微血管病性溶血性贫血。脑成像检查发现了颅内出血。进一步检测发现,ADAMTS13活性低(1.8%),抗ADAMTS13抗体阳性,确诊为血栓性血小板减少性紫癜。经过抗结核治疗、血浆置换和支持治疗后,患者完全康复。我们介绍了这一罕见病例,并回顾了以往的相关研究,以提醒临床医生注意结核病与血栓性血小板减少性紫癜之间的潜在联系。对于有严重血小板减少和微血管病性溶血症状的患者,应进行必要的诊断性检查,以排除结核病并发血栓性血小板减少性紫癜的可能性。
{"title":"Pulmonary Tuberculosis Complicated by Thrombotic Thrombocytopenic Purpura: A Case Report and Literature Review.","authors":"Jun Zheng, Xiaohong Pan, Yiyun Jiang","doi":"10.2147/IDR.S477180","DOIUrl":"10.2147/IDR.S477180","url":null,"abstract":"<p><p>Thrombotic thrombocytopenic purpura is a rare but life-threatening emergency. Tuberculosis can have hematologic complications. However, concurrent tuberculosis and thrombotic thrombocytopenic purpura are extremely rare. In this study, we report a 53-year-old man who was initially treated for pulmonary tuberculosis but later developed weakness and an altered mental status. Laboratory tests revealed evidence of thrombocytopenia, acute renal insufficiency, and microangiopathic hemolytic anemia. Brain imaging identified intracranial hemorrhage. Further testing revealed low ADAMTS13 activity (1.8%) and positive anti-ADAMTS13 antibody, confirming the diagnosis of thrombotic thrombocytopenic purpura. The patient had a full recovery after anti-tuberculosis treatment, plasma exchange, and supportive care. We present this rare case and review previous relevant studies to remind clinicians about the potential connections between tuberculosis and thrombotic thrombocytopenic purpura. In patients with signs of severe thrombocytopenia and microangiopathic hemolysis, necessary diagnostic tests should be performed to eliminate the possibility of thrombotic thrombocytopenic purpura occurring concurrently with tuberculosis.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11338169/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142017387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utility of Metagenomic Next-Generation Sequencing for Diagnosis of Infectious Diseases in Critically Ill Immunocompromised Pediatric Patients. 元基因组下一代测序技术在诊断重症免疫力低下儿科患者传染病中的应用
IF 2.9 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-08-16 eCollection Date: 2024-01-01 DOI: 10.2147/IDR.S472129
Xiangzhi Xu, Yafeng Zheng, Xiaojing Zhang, Chenmei Zhang, Wei Gai, Zihao Yang

Purpose: Infections cause high rates of illness and death in children worldwide. However, studies on the clinical value of metagenomic next-generation sequencing (mNGS) for immunocompromised children are still limited.

Patients and methods: From June 2021 to December 2023, 119 samples were collected at Pediatric Intensive Care Unit (PICU) of a single-center pediatric hospital and classified into two groups based on their immune states. We compared the diagnostic performance of mNGS and conventional microbiological test (CMT) for pathogen identification, and assessed the clinical impacts of mNGS.

Results: Among the 119 samples, 48 (40.34%) belonged to the immunocompromised children. mNGS had a higher positivity rate than CMT (76.47% vs 55.46%, P = 0.0006). The positive percent agreement (PPA) of mNGS for immunocompromised children was higher compared to immunocompetent children (95.24% vs 77.78%). The most common pathogens for immunocompromised patients were gram-negative bacteria and herpesvirus. However, immunocompetent children showed a higher detection rate for gram-positive bacteria and respiratory viruses. Furthermore, the proportions of the positive impact of mNGS results were significantly higher in immunocompromised patients compared to immunocompetent patients for both diagnosis (91.67% vs 57.75%) and treatment (95.83% vs 64.79%) (P < 0.0001). Immunocompromised state, length of hospital stays, times stay in ICU, Pediatric Risk of Mortality (PRISM) score, neutrophil percentage (NEUT%) and the ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO2/FiO2) were considered independent factors for poor prognosis in critically ill pediatric patients.

Conclusion: In patients from PICU, mNGS had a greater clinical significance in immunocompromised children compared to immunocompetent children. mNGS technology is an important auxiliary method for achieving accurate diagnosis and treatment of critically ill pediatric patients.

目的:感染导致全球儿童患病率和死亡率居高不下。然而,针对免疫力低下儿童的元基因组新一代测序(mNGS)的临床价值研究仍然有限:从 2021 年 6 月到 2023 年 12 月,我们在一家单中心儿科医院的儿科重症监护室(PICU)收集了 119 份样本,并根据其免疫状态分为两组。我们比较了 mNGS 和传统微生物检验(CMT)对病原体鉴定的诊断性能,并评估了 mNGS 的临床影响:在 119 份样本中,48 份(40.34%)属于免疫力低下的儿童。mNGS 的阳性率高于 CMT(76.47% vs 55.46%,P = 0.0006)。与免疫功能健全的儿童相比,免疫功能低下儿童的 mNGS 阳性率(PPA)更高(95.24% vs 77.78%)。免疫力低下患者最常见的病原体是革兰氏阴性细菌和疱疹病毒。然而,免疫功能正常的儿童对革兰氏阳性细菌和呼吸道病毒的检出率更高。此外,在诊断(91.67% vs 57.75%)和治疗(95.83% vs 64.79%)方面,免疫力低下患者的 mNGS 结果产生积极影响的比例明显高于免疫力健全患者(P < 0.0001)。免疫受损状态、住院时间、在重症监护室的住院时间、儿科死亡率风险(PRISM)评分、中性粒细胞百分比(NEUT%)和动脉血氧分压与分量吸入氧(PaO2/FiO2)之比被认为是儿科重症患者预后不良的独立因素:mNGS 技术是实现儿科重症患者准确诊断和治疗的重要辅助方法。
{"title":"Utility of Metagenomic Next-Generation Sequencing for Diagnosis of Infectious Diseases in Critically Ill Immunocompromised Pediatric Patients.","authors":"Xiangzhi Xu, Yafeng Zheng, Xiaojing Zhang, Chenmei Zhang, Wei Gai, Zihao Yang","doi":"10.2147/IDR.S472129","DOIUrl":"10.2147/IDR.S472129","url":null,"abstract":"<p><strong>Purpose: </strong>Infections cause high rates of illness and death in children worldwide. However, studies on the clinical value of metagenomic next-generation sequencing (mNGS) for immunocompromised children are still limited.</p><p><strong>Patients and methods: </strong>From June 2021 to December 2023, 119 samples were collected at Pediatric Intensive Care Unit (PICU) of a single-center pediatric hospital and classified into two groups based on their immune states. We compared the diagnostic performance of mNGS and conventional microbiological test (CMT) for pathogen identification, and assessed the clinical impacts of mNGS.</p><p><strong>Results: </strong>Among the 119 samples, 48 (40.34%) belonged to the immunocompromised children. mNGS had a higher positivity rate than CMT (76.47% vs 55.46%, <i>P</i> = 0.0006). The positive percent agreement (PPA) of mNGS for immunocompromised children was higher compared to immunocompetent children (95.24% vs 77.78%). The most common pathogens for immunocompromised patients were gram-negative bacteria and herpesvirus. However, immunocompetent children showed a higher detection rate for gram-positive bacteria and respiratory viruses. Furthermore, the proportions of the positive impact of mNGS results were significantly higher in immunocompromised patients compared to immunocompetent patients for both diagnosis (91.67% vs 57.75%) and treatment (95.83% vs 64.79%) (<i>P</i> < 0.0001). Immunocompromised state, length of hospital stays, times stay in ICU, Pediatric Risk of Mortality (PRISM) score, neutrophil percentage (NEUT%) and the ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO2/FiO2) were considered independent factors for poor prognosis in critically ill pediatric patients.</p><p><strong>Conclusion: </strong>In patients from PICU, mNGS had a greater clinical significance in immunocompromised children compared to immunocompetent children. mNGS technology is an important auxiliary method for achieving accurate diagnosis and treatment of critically ill pediatric patients.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11334925/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142008692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular Characterization of a KPC-2- and NDM-1-Producing Klebsiella michiganensis Clinical Isolate in Cerebrospinal Fluid. 脑脊液中产生 KPC-2 和 NDM-1 的密歇根克雷伯氏菌临床分株的分子特征。
IF 2.9 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-08-16 eCollection Date: 2024-01-01 DOI: 10.2147/IDR.S468895
Mingyue Sun, Weiqiang Xiao, Qingxia Xu

Objective: Klebsiella michiganensis is an emerging pathogen. In this context, we characterised a strain fxq isolated from a cerebrospinal fluid specimen of a patient with tentorial meningioma, and the K. michiganensis isolate produced carbapenemases of KPC and NDM types.

Methods: The Phoenix 100 Automated Microbiology System, MALDI-TOF and whole-genome sequencing were used to identify the species. Anti-microbial susceptibility testing was also conducted with the Phoenix 100. The plasmid locations of the bla KPC-2 and bla NDM-1 genes were determined by S1-nuclease pulsed-field gel electrophoresis and Southern blot. The transfer capacity of plasmids carrying bla KPC-2 and bla NDM-1 was investigated by conjugation experiments, and the resistance plasmid stability was evaluated by culture and subculture. K. michiganensis subtypes were identified by multi-locus sequence typing. We performed whole-genome sequencing to confirm species, characterise plasmids and analyse core genes.

Results: fxq was originally identified as Klebsiella oxytoca and showed resistance to imipenem and meropenem, but whole-genome sequencing identified it to be K. michiganensis. The strain fxq belonged to the novel sequence type 202 (ST202) and carried the bla KPC-2 and bla NDM-1 genes located on the pB_KPC InFIA and pE_NDM IncU plasmids, respectively. The bla KPC-2-carrying plasmid was successfully transferred to Escherichia coli EC600 by conjugation, whereas the bla NDM-1 gene on the pE_NDM plasmid was not. The pB_KPC and pE_NDM plasmids demonstrated high stability.

Conclusion: This work is the first report on a carbapenem-resistant clinical isolate K. michiganensis ST202 harbouring the bla KPC-2 and bla NDM-1 genes encoded by the IncFIA and IncU plasmids, respectively.

目的:密歇根克雷伯氏菌是一种新出现的病原体。在此背景下,我们对从一名触珠状脑膜瘤患者的脑脊液标本中分离出的一株 fxq 菌株进行了鉴定,结果表明该米奇根氏克雷伯菌可产生 KPC 和 NDM 型碳青霉烯酶:方法:使用 Phoenix 100 自动化微生物学系统、MALDI-TOF 和全基因组测序鉴定菌种。还使用 Phoenix 100 进行了抗微生物药敏试验。通过 S1 核酸酶脉冲场凝胶电泳和 Southern 印迹确定了 bla KPC-2 和 bla NDM-1 基因的质粒位置。通过连接实验研究了携带 bla KPC-2 和 bla NDM-1 的质粒的转移能力,并通过培养和亚培养评估了抗性质粒的稳定性。通过多焦点序列分型鉴定了 K. michiganensis 亚型。我们进行了全基因组测序,以确认菌种、鉴定质粒并分析核心基因。结果:fxq最初被鉴定为克雷伯氏菌(Klebsiella oxytoca),并显示出对亚胺培南和美罗培南的耐药性,但全基因组测序确定其为K. michiganensis。fxq 菌株属于新型序列类型 202(ST202),携带 bla KPC-2 和 bla NDM-1 基因,分别位于 pB_KPC InFIA 和 pE_NDM IncU 质粒上。携带 bla KPC-2 基因的质粒通过连接成功转移到了大肠杆菌 EC600 中,而 pE_NDM 质粒上的 bla NDM-1 基因则没有成功转移。pB_KPC 和 pE_NDM 质粒表现出很高的稳定性:本研究首次报道了耐碳青霉烯类药物的临床分离株 K. michiganensis ST202 携带分别由 IncFIA 和 IncU 质粒编码的 bla KPC-2 和 bla NDM-1 基因。
{"title":"Molecular Characterization of a KPC-2- and NDM-1-Producing <i>Klebsiella michiganensis</i> Clinical Isolate in Cerebrospinal Fluid.","authors":"Mingyue Sun, Weiqiang Xiao, Qingxia Xu","doi":"10.2147/IDR.S468895","DOIUrl":"10.2147/IDR.S468895","url":null,"abstract":"<p><strong>Objective: </strong><i>Klebsiella michiganensis</i> is an emerging pathogen. In this context, we characterised a strain fxq isolated from a cerebrospinal fluid specimen of a patient with tentorial meningioma, and the <i>K. michiganensis</i> isolate produced carbapenemases of KPC and NDM types.</p><p><strong>Methods: </strong>The Phoenix 100 Automated Microbiology System, MALDI-TOF and whole-genome sequencing were used to identify the species. Anti-microbial susceptibility testing was also conducted with the Phoenix 100. The plasmid locations of the <i>bla</i> <sub>KPC-2</sub> and <i>bla</i> <sub>NDM-1</sub> genes were determined by S1-nuclease pulsed-field gel electrophoresis and Southern blot. The transfer capacity of plasmids carrying <i>bla</i> <sub>KPC-2</sub> and <i>bla</i> <sub>NDM-1</sub> was investigated by conjugation experiments, and the resistance plasmid stability was evaluated by culture and subculture. <i>K. michiganensis</i> subtypes were identified by multi-locus sequence typing. We performed whole-genome sequencing to confirm species, characterise plasmids and analyse core genes.</p><p><strong>Results: </strong>fxq was originally identified as <i>Klebsiella oxytoca</i> and showed resistance to imipenem and meropenem, but whole-genome sequencing identified it to be <i>K. michiganensis</i>. The strain fxq belonged to the novel sequence type 202 (ST202) and carried the <i>bla</i> <sub>KPC-2</sub> and <i>bla</i> <sub>NDM-1</sub> genes located on the pB_KPC InFIA and pE_NDM IncU plasmids, respectively. The <i>bla</i> <sub>KPC-2</sub>-carrying plasmid was successfully transferred to <i>Escherichia coli</i> EC600 by conjugation, whereas the <i>bla</i> <sub>NDM-1</sub> gene on the pE_NDM plasmid was not. The pB_KPC and pE_NDM plasmids demonstrated high stability.</p><p><strong>Conclusion: </strong>This work is the first report on a carbapenem-resistant clinical isolate <i>K. michiganensis</i> ST202 harbouring the <i>bla</i> <sub>KPC-2</sub> and <i>bla</i> <sub>NDM-1</sub> genes encoded by the IncFIA and IncU plasmids, respectively.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11334930/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142008691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cervical Brucella Spondylitis: A Case Report on Diagnosis and Surgical Management. 颈椎布鲁氏菌脊柱炎:关于诊断和手术治疗的病例报告。
IF 2.9 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-08-14 eCollection Date: 2024-01-01 DOI: 10.2147/IDR.S474589
Bo Liu, Yao Zhang, Zheng Yuan, Qiang Zhang

Background: Brucellosis is a zoonotic disease that can affect various organs, including the spine. Cervical spondylitis caused by Brucella is rare but can lead to significant morbidity if not diagnosed and treated promptly.

Case presentation: We report a case of a 46-year-old female who presented with intermittent high fever and intractable neck, shoulder, and back pain for two months. She was diagnosed with Brucella cervical spondylitis based on clinical manifestations, Rose-Bengal Plate Agglutination Test (RBPT, positive), and cervical MRI findings. She was treated with a combination of antibiotics for at least two weeks, followed by surgical intervention including abscess clearance, partial vertebral resection, and titanium mesh bone fusion. Real-time Polymerase Chain Reaction (RT-PCR) confirmed the presence of sheep Brucella DNA. The patient recovered well postoperatively with significant pain reduction and restoration of full mobility in the right upper limb.

Conclusion: This case highlights the diagnostic value of RT-PCR and tissue biopsy in cervical brucellosis spondylitis. Our study found that anterior cervical subtotal corpectomy can restore cervical stability, clear abscess, and relieve spinal cord compression on the basis of drug treatment, with good clinical results.

背景:布鲁氏菌病是一种人畜共患病,可影响包括脊柱在内的多个器官。由布鲁氏菌引起的颈椎炎非常罕见,但如果不及时诊断和治疗,会导致严重的发病率:我们报告了一例 46 岁女性的病例,她出现间歇性高烧和顽固性颈、肩和背部疼痛两个月。根据临床表现、玫瑰-孟加拉平板凝集试验(RBPT,阳性)和颈椎磁共振成像结果,她被诊断为布鲁氏杆菌颈椎炎。她接受了至少两周的联合抗生素治疗,随后接受了手术治疗,包括脓肿清除、部分椎体切除和钛网骨融合术。实时聚合酶链反应(RT-PCR)证实了羊布鲁氏杆菌 DNA 的存在。患者术后恢复良好,疼痛明显减轻,右上肢恢复了完全活动能力:本病例凸显了 RT-PCR 和组织活检在颈部布鲁氏菌脊柱炎中的诊断价值。我们的研究发现,前路颈椎次全椎体切除术可在药物治疗的基础上恢复颈椎稳定性、清除脓肿、解除脊髓压迫,临床效果良好。
{"title":"Cervical <i>Brucella</i> Spondylitis: A Case Report on Diagnosis and Surgical Management.","authors":"Bo Liu, Yao Zhang, Zheng Yuan, Qiang Zhang","doi":"10.2147/IDR.S474589","DOIUrl":"10.2147/IDR.S474589","url":null,"abstract":"<p><strong>Background: </strong><i>Brucellosis</i> is a zoonotic disease that can affect various organs, including the spine. Cervical spondylitis caused by <i>Brucella</i> is rare but can lead to significant morbidity if not diagnosed and treated promptly.</p><p><strong>Case presentation: </strong>We report a case of a 46-year-old female who presented with intermittent high fever and intractable neck, shoulder, and back pain for two months. She was diagnosed with <i>Brucella</i> cervical spondylitis based on clinical manifestations, Rose-Bengal Plate Agglutination Test (RBPT, positive), and cervical MRI findings. She was treated with a combination of antibiotics for at least two weeks, followed by surgical intervention including abscess clearance, partial vertebral resection, and titanium mesh bone fusion. Real-time Polymerase Chain Reaction (RT-PCR) confirmed the presence of sheep <i>Brucella</i> DNA. The patient recovered well postoperatively with significant pain reduction and restoration of full mobility in the right upper limb.</p><p><strong>Conclusion: </strong>This case highlights the diagnostic value of RT-PCR and tissue biopsy in cervical brucellosis spondylitis. Our study found that anterior cervical subtotal corpectomy can restore cervical stability, clear abscess, and relieve spinal cord compression on the basis of drug treatment, with good clinical results.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11330751/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142004123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Infection and Drug Resistance
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1